Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.
about
Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions.Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance.The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ.Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate.LAG-3+ tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+ tumors.CD14+ HLA-DR-/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation.The Predictive and Prognostic Role of Stromal Tumor-infiltrating Lymphocytes in HER2-positive Breast Cancer with Trastuzumab-based Treatment: a Meta-analysis and Systematic Review.Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma.Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years.Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden.Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer.N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients - association with tumor biology and clinical outcome.FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment.Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.Breast Cancer Immunotherapy: An Update.Luminal A Breast Cancer and Molecular Assays: A ReviewPredictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
P2860
Q38639746-4E5588BC-9C55-4B51-9270-4C4B045C40B2Q38661390-BBAAA40C-E1A6-4C31-B478-526FAF753BD7Q39421814-C7C9B8BE-DF32-4B9A-A74F-BFA5782557D9Q41625138-CEFA4FDF-07C0-4E75-8FB2-0187FFD1428AQ41701208-4C413C5E-8C11-4B95-A8BE-7ADB0E5B70E9Q41705524-39D348FD-FA4A-436E-B516-082171F8A7ADQ42517038-0E4B3788-BB91-4166-9765-300E76C57F37Q46243184-CF7B3EAB-BC32-4B4E-8E5E-51E028EA555CQ47109695-9C3CB744-DA9C-4764-BF97-78D2E4131FA6Q47123925-FF88271F-CC64-43F3-B11A-573A9C613EB8Q47260496-725FD3E5-BA49-4B97-A0F1-3320F6B23FD4Q48102534-43E4E892-DEF1-4E84-B93E-FBFE4D68199BQ48341168-7BA81567-A097-4337-BAEF-EEA056175ED1Q50088564-47332709-3482-4856-8B3D-902DF60F4BEDQ52308791-ABCDDDCD-5240-425E-B754-D84D4E08ECB5Q52599656-58E75312-EBB8-4297-A334-0FC1EEDD469AQ52671150-1CF78CDD-E23A-49FC-B16F-17DDED88C90EQ55360303-0B9E0612-C488-4C95-AFF8-98E8D0FF9F27Q57113322-D213DC09-8930-48C1-96E5-6E7E1A0B2F74Q58781862-0F9DC398-8809-431B-9FF3-47E5731FB2A7
P2860
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tumor-Infiltrating Lymphocytes ...... d HER2-Positive Breast Cancer.
@en
type
label
Tumor-Infiltrating Lymphocytes ...... d HER2-Positive Breast Cancer.
@en
prefLabel
Tumor-Infiltrating Lymphocytes ...... d HER2-Positive Breast Cancer.
@en
P2093
P50
P1476
Tumor-Infiltrating Lymphocytes ...... d HER2-Positive Breast Cancer.
@en
P2093
Angelika Ober
Barbara Ingold Heppner
Berit M Pfitzner
Christine Solbach
Dirk M Zahm
Esther Heck
Frank Holms
Hans Tesch
Holger Eidtmann
Jörg-Olaf Habeck
P304
P356
10.1158/1078-0432.CCR-15-2338
P407
P577
2016-05-17T00:00:00Z